ArticleMayo Clinic proceedings. Innovations, quality & outcomes2026
When Refractory Is Not the End: Redefining Chronic Cough Through Tertiary Center Evaluation.
Article in Mayo Clinic proceedings. Innovations, quality & outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe the clinical outcomes of refractory chronic cough (RCC) diagnosis and management at a tertiary care chronic cough clinic. Patients and Methods: This is a prospective study of all eligible patients referred to the Mayo Clinic Chronic Cough Clinic between October 6, 2020 and April 9, 2021. All adult patients aged 18 years or older with cough persisting beyond 8 weeks in accordance with the American College of Chest Physicians definition were screened. Only participants with research authorization and consent were included in this study. Results: A total of 278 patients were screened; 100 patients were enrolled in this study. On the initial visit, 56 patients who were considered to have RCC were invited for a 3-month follow-up survey. Of those 56 patients, electronic health record review clarified that 35 (62%) had etiology-confirmed chronic cough 21 (37%) patients had unexplained chronic cough. Conclusion: This study shows that RCC needs further attentiveness toward diagnosis and trials of therapy to truly ascertain those who have unexplained chronic cough such as at specialized chronic cough centers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.